Holen Sie sich die Stockscreener-App
5.71
1.96%
0.11
Handel nachbörslich:
5.69
-0.02
-0.35%
Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten
104,535 Shares in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Bought by Quest Partners LLC - MarketBeat
Terns Pharmaceuticals (TERN) Stock Drops Over 5% Amidst Mixed In - GuruFocus.com
Terns Pharmaceuticals appoints new board member - Investing.com
Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - GlobeNewswire
Terns Pharmaceuticals, Inc. Announces Board Changes - Marketscreener.com
Terns Pharmaceuticals (NASDAQ:TERN) Stock Price Down 8.7%Should You Sell? - MarketBeat
Steven Cohen's Strategic Acquisition in Terns Pharmaceuticals Inc - GuruFocus.com
Insiders Re-Evaluate Their US$5.05m Stock Purchase As Terns Pharmaceuticals Falls To US$556m - Simply Wall St
Research Analysts Issue Forecasts for TERN FY2024 Earnings - Defense World
HC Wainwright Has Bullish Forecast for TERN FY2024 Earnings - MarketBeat
Q1 Earnings Forecast for TERN Issued By HC Wainwright - MarketBeat
We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth - Yahoo Finance
Terns Pharmaceuticals Reports Q3 Progress and Financials - TipRanks
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Terns Pharmaceuticals Inc Reports Q3 2024 Net Loss Per Share of $0.28, Cash Position Strengthened to $372.8 Million - GuruFocus.com
Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates - GlobeNewswire
Creative Planning Purchases 5,409 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences - The Manila Times
Terns Pharmaceuticals to Present at UBS and Jefferies Healthcare Conferences in November | TERN Stock News - StockTitan
Where are the Opportunities in (TERN) - Stock Traders Daily
This small-cap stock is expected to take off — if its weight-loss pill trial succeeds - MSN
Terns Surges 29.6% in Three Months: Will the Momentum Continue? - MSN
Critical Survey: Madrigal Pharmaceuticals (NASDAQ:MDGL) vs. Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $15.90 - Defense World
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Oppenheimer initiates Terns Pharmaceuticals stock at Outperform, sees 150% upside - Investing.com Australia
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $15.90 Average Target Price from Analysts - MarketBeat
Terns Pharmaceuticals (NASDAQ:TERN) Coverage Initiated by Analysts at Oppenheimer - MarketBeat
Objective long/short (TERN) Report - Stock Traders Daily
Bleakley Financial Group LLC Purchases 2,751 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
SG Americas Securities LLC Buys Shares of 23,810 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns identifies new GLP-1R agonists - BioWorld Online
Financial Comparison: Oculis (NASDAQ:OCS) and Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
Will The LIFT Data Boost Terns Stock? - RTTNews
Terns Pharmaceuticals: Another Potential GLP-1 Entrant (NASDAQ:TERN) - Seeking Alpha
Top investors say Terns Pharmaceuticals Inc (TERN) ticks everything they need - SETE News
(TERN) Technical Pivots with Risk Controls - Stock Traders Daily
A stock that deserves closer examination: Terns Pharmaceuticals Inc (TERN) - US Post News
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Short Interest Update - MarketBeat
Mizuho gives a Buy recommendation for Terns Pharmaceuticals Inc (TERN) - Knox Daily
Why Terns Pharmaceuticals Inc Stock Might Make Sense If Bought Today - Stocks Register
Marshall Wace LLP Decreases Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Sold by Marshall Wace LLP - MarketBeat
Institutional investors in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) lost 9.7% last week but have reaped the benefits of longer-term growth - Simply Wall St
Terns Pharmaceuticals (NASDAQ:TERN) Stock Price Down 6.2%Here's Why - MarketBeat
Terns Pharmaceuticals Inc (TERN) looking to reclaim success with recent performance - SETE News
Buying Buzz: Terns Pharmaceuticals Inc [TERN] Director Lu Hongbo purchases 476,190 shares of the company - Knox Daily
Renaissance Technologies LLC Takes Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - MarketBeat
Terns Pharmaceuticals Inc: Rising -32.47% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Gaining Ground: Terns Pharmaceuticals Inc (TERN) Closes Higher at 8.27, Up 0.85 - The Dwinnex
Understanding the Risks of Investing in Terns Pharmaceuticals Inc (TERN) - Knox Daily
How to interpret Terns Pharmaceuticals Inc (TERN)’s stock chart patterns - US Post News
Trend Tracker for (TERN) - Stock Traders Daily
Ready to Jump After Recent Trade: Terns Pharmaceuticals Inc (TERN) - SETE News
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):